Verastem | VSTM - Ebit

Stock Price
5.82
Daily Change
-0.02 -0.34%
Monthly
-14.29%
Yearly
-2.51%
Q1 Forecast
5.64

Verastem reported $-37.03M in EBIT for its fiscal quarter ending in September of 2024.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Curis USD -12.37M 230K Sep/2023
Cytokinetics USD -166.76M 55.25M Sep/2025
Gilead Sciences USD 2.96B 551M Dec/2025
Incyte USD 383.88M 47.44M Dec/2025
Laboratory Of America USD 462.8M 6.2M Jun/2025
Novartis USD -9.19B 13.87B Jun/2025
Pfizer USD 4.65B 71M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
TG Therapeutics USD 29.36M 5.48M Sep/2025
Verastem USD -37.03M 6M Sep/2024